Trials / Completed
CompletedNCT05135286
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 629 (actual)
- Sponsor
- Visus Therapeutics · Academic / Other
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Detailed description
Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BRIMOCHOL™ PF | A single drop in each eye at a visit. |
| DRUG | Carbachol PF | A single drop in each eye at a visit. |
| DRUG | Vehicle | A single drop in each eye at a visit. |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2025-03-13
- Completion
- 2025-03-13
- First posted
- 2021-11-26
- Last updated
- 2025-08-06
Locations
42 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05135286. Inclusion in this directory is not an endorsement.